TABLE 1.
Characteristic by patient groupa | Data |
---|---|
Enrolled subjects with correctly processed WB samples | |
Total no. | 161 |
Age (median [range]) (yr) | 41 (18–79) |
No. (%) of females | 89 (55) |
Patients presenting to OCPHS TB Clinic | |
No. enrolled | 42 |
Age (median [range]) (yr) | 36 (18–79) |
No. (%) of females | 20 (48) |
Region of birth (no. [%]) | |
Asia | 10 (23.8) |
Africa and Middle East | 23 (54.8) |
South America | 3 (7.1) |
North America | 6 (14.3) |
No. (%) BCG vaccinated | 13 (31) |
TB status | |
Active TB Dx | 3 (7.1) |
LTBI, partial, or no Tx | 28 (66.7) |
LTBI, Tx completed | 1 (2.4) |
No LTBI | 10 (23.8) |
Health care workers | |
No. enrolled | 119 |
Age (median [range]) (yr) | 41 (25–62) |
No. (%) of females | 69 (58) |
No. of HCWs with reactive TST ≥10 mm (% of total HCWs) | 19 (16) |
BCG vaccinatedb | 5 (26.3) |
Documented Tx Hx for LTBIb | 7 (36.8) |
Unknown Tx Hx for LTBIb | 3 (15.8) |
No LTBIb,c | 9 (47.4) |
WB, whole blood; TB, tuberculosis; BCG, bacille Calmette-Guerin; Dx, diagnosis; Tx, treatment; Hx, history; LTBI, latent tuberculosis infection.
Percentage calculated using the number of patients with reactive TST results as the denominator (n = 19).
A reactive TST result was considered false positive.